T1	Participants 56 90	proliferative diabetic retinopathy
T2	Participants 328 494	A prospective, fellow-eye sham controlled clinical trial was conducted on 80 eyes of 40 high-risk characteristic proliferative diabetic retinopathy type II diabetics.
T3	Participants 923 1000	median age was 52 years (range: 39-68) and 30% of the participants were male.
